Physician profile
Michael E Farrell
NPI 1972811628
$23,367.50
in general payments reported to CMS, 2019-2025
18 companies · $6,077 in 2025
The $6,077 reported for 2025 was more than what 92% of Interventional Pain Medicine providers received nationally (typical 2025 total: $676).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $639 · 2022: $637 · 2023: $12K · 2024: $4,344 · 2025: $6,077.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $8,512 · Food and Beverage: $7,180 · Compensation For Serving As Faculty Or As A Speaker For A Medical Education Program: $4,000 · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $2,400.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $8,511.87 |
| Food and Beverage | $7,180.16 |
| Compensation For Serving As Faculty Or As A Speaker For A Medical Education Program | $4,000.00 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $2,400.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $14,848.80 | 2022-2025 | Proclaim, Octrode, Infinity |
| Saluda Medical Americas, INC. | $2,621.39 | 2023-2025 | Evoke Scs, Evoke |
| Nevro Corp. | $1,473.34 | 2022-2024 | Senza |
| Relievant Medsystems, INC. | $1,356.48 | 2023 | Intracept |
| Medtronic, INC. | $732.68 | 2021-2025 | Intellis Adaptivestim, Inceptiv |
| Vertos Medical, INC. | $655.86 | 2022-2024 | Mild Device Kit |
| Boston Scientific Corporation | $648.98 | 2022-2025 | General - Pain Management, Intracept |
| Globus Medical, INC. | $495.61 | 2025 | Senza, Vyrsa V1, Nevro |
| Nalu Medical, INC. | $138.00 | 2024 | Nalu Neurostimulation System |
| Spr Therapeutics, INC | $86.40 | 2024-2025 | Sprint Pns System |
| Avanos Medical | $72.68 | 2025 | |
| Collegium Pharmaceutical, INC. | $70.28 | 2023-2024 | Belbuca, Xtampza |
| Becton, Dickinson and Company | $34.76 | 2024 | |
| Curonix LLC | $33.35 | 2024 | Pns Freedom-4a Permanent Neurostimulator Receiver Kit Channel A |
| Stryker Corporation | $30.39 | 2024 | Mild Device Kit |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Merck Sharp & Dohme LLC | $26.98 | 2023 | Verquvo |
| Si-Bone, INC. | $20.85 | 2025 | |
| Sanofi Pasteur INC. | $20.67 | 2023 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Michael Farrell listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.